NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

0.0%

Nov 3 11:17 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Patrick Carter who wrote (46)	3/17/1998 4:27:00 PM
From: Russian Bear	Read Replies (2) of 132

I am maintaining my entire short position. This one smells "fishy." For a development stage company, without clinical trial results, without an identifiable patent base, without even a "clean" publication, to hold onto this sort of a gain in its stock would surprise me greatly. My question is, Who is selling all these shares? 1.6 million traded yesterday, another 2 million traded today -- even taking the NASD double-counting system into account, that still amounts to 1.5 to 2 million "real" shares traded. Shortsellers did not sell all these shares. Maybe someone wanted out, hence yesterday's little PR stunt. Why would it not surprise me, if, in the future, we were to learn that insiders were heavy net sellers these last two days? I guess it is just the cynic in me. RB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next